⌘K

Home/Filings/4/0001209191-23-022689

4//SEC Filing

Ambrose Kristen 4

Accession 0001209191-23-022689

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:18 PM ET

Size

4.6 KB

Accession

0001209191-23-022689

Insider Transaction Report

Form 4

Period: 2023-03-31

VERTEX PHARMACEUTICALS INC / MAVRTX

Ambrose Kristen

SVP & Chief Accounting Officer

Transactions

Tax Payment
Common Stock
2023-03-31$313.74/sh−176$55,218→ 7,127 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001856587

Filing Metadata

Form type: 4
Filed: Apr 3, 8:00 PM ET
Accepted: Apr 4, 4:18 PM ET
Size: 4.6 KB

View on SEC.gov